Intec Pharma Ltd. (NTEC) Analysts See $-0.28 EPS; Park West Asset Management Has Trimmed Netgear (NTGR) Stake

May 18, 2018 - By Matthew Harris

Intec Pharma Ltd. (NASDAQ:NTEC) Logo

Park West Asset Management Llc decreased Netgear Inc (NTGR) stake by 3.17% reported in 2017Q4 SEC filing. Park West Asset Management Llc sold 25,323 shares as Netgear Inc (NTGR)’s stock declined 1.13%. The Park West Asset Management Llc holds 774,677 shares with $45.51M value, down from 800,000 last quarter. Netgear Inc now has $1.89 billion valuation. The stock increased 0.76% or $0.45 during the last trading session, reaching $59.8. About 178,942 shares traded. NETGEAR, Inc. (NASDAQ:NTGR) has risen 14.10% since May 18, 2017 and is uptrending. It has outperformed by 2.55% the S&P500.

Analysts expect Intec Pharma Ltd. (NASDAQ:NTEC) to report $-0.28 EPS on June, 8.After having $-0.39 EPS previously, Intec Pharma Ltd.’s analysts see -28.21% EPS growth. The stock decreased 3.09% or $0.15 during the last trading session, reaching $4.7. About 210,925 shares traded. Intec Pharma Ltd. (NASDAQ:NTEC) has risen 25.00% since May 18, 2017 and is uptrending. It has outperformed by 13.45% the S&P500.

Investors sentiment decreased to 1.08 in Q4 2017. Its down 0.08, from 1.16 in 2017Q3. It fall, as 23 investors sold NTGR shares while 65 reduced holdings. 43 funds opened positions while 52 raised stakes. 32.13 million shares or 2.55% more from 31.32 million shares in 2017Q3 were reported. Fincl Bank Of America De has 277,041 shares for 0% of their portfolio. Rhumbline Advisers holds 0.01% or 78,097 shares. Gagnon Securities Llc holds 0.63% or 30,372 shares in its portfolio. Meeder Asset Mngmt Inc, a Ohio-based fund reported 877 shares. Ubs Asset Americas reported 0% of its portfolio in NETGEAR, Inc. (NASDAQ:NTGR). Prudential Finance owns 55,194 shares. Metropolitan Life Insur New York has invested 0.01% of its portfolio in NETGEAR, Inc. (NASDAQ:NTGR). Geode Capital Management Ltd Liability accumulated 284,466 shares. Deutsche Bank Ag holds 0.01% in NETGEAR, Inc. (NASDAQ:NTGR) or 306,447 shares. Amalgamated Bank & Trust invested 0.01% in NETGEAR, Inc. (NASDAQ:NTGR). Dean Cap Mngmt reported 1.19% of its portfolio in NETGEAR, Inc. (NASDAQ:NTGR). Balyasny Asset Mgmt Limited Com has 0.01% invested in NETGEAR, Inc. (NASDAQ:NTGR) for 49,423 shares. Proshare Advsrs Ltd Limited Liability Company reported 5,601 shares. Carroll Financial Assoc Inc has invested 0% of its portfolio in NETGEAR, Inc. (NASDAQ:NTGR). 103,799 are owned by Tiaa Cref Limited Liability Company.

More notable recent NETGEAR, Inc. (NASDAQ:NTGR) news were published by: Nasdaq.com which released: “All-New Arlo Security Light System Illuminates Outdoor Areas and Provides Alerts Against Potential Threats” on May 15, 2018, also Seekingalpha.com with their article: “Netgear beats profit expectations despite decline” published on April 25, 2018, Globenewswire.com published: “NETGEAR® Reports First Quarter 2018 Results” on April 25, 2018. More interesting news about NETGEAR, Inc. (NASDAQ:NTGR) were released by: Streetinsider.com and their article: “After-Hours Movers 4/25: (ORLY) (AMD) (FB) Higher; (FARO) (NTGR) (T) Lower (more…)” published on April 25, 2018 as well as Nasdaq.com‘s news article titled: “NETGEAR Debuts Industry-First Orbi Tri-Band Mesh WiFi Cable Modem Router System” with publication date: May 08, 2018.

Park West Asset Management Llc increased Liberty Media Corp Delaware stake by 20,000 shares to 1.02M valued at $22.53 million in 2017Q4. It also upped Social Cap Hedosophia Hldgs stake by 526,564 shares and now owns 1.63M shares. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) was raised too.

Among 7 analysts covering Netgear (NASDAQ:NTGR), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Netgear had 14 analyst reports since October 23, 2015 according to SRatingsIntel. On Wednesday, June 8 the stock rating was initiated by Wunderlich with “Buy”. Rosenblatt maintained the shares of NTGR in report on Tuesday, February 9 with “Buy” rating. RBC Capital Markets maintained the shares of NTGR in report on Tuesday, November 17 with “Sector Perform” rating. The rating was initiated by Sterne Agee CRT on Tuesday, April 5 with “Neutral”. The firm earned “Buy” rating on Thursday, September 8 by Wunderlich. Guggenheim maintained NETGEAR, Inc. (NASDAQ:NTGR) on Wednesday, January 17 with “Buy” rating. The firm has “Mkt Perform” rating given on Wednesday, February 8 by Raymond James. BWS Financial downgraded NETGEAR, Inc. (NASDAQ:NTGR) on Monday, October 3 to “Hold” rating. The rating was upgraded by BWS Financial to “Buy” on Monday, October 9. On Friday, October 23 the stock rating was upgraded by Raymond James to “Outperform”.

Analysts await NETGEAR, Inc. (NASDAQ:NTGR) to report earnings on July, 25. They expect $0.52 earnings per share, up 6.12% or $0.03 from last year’s $0.49 per share. NTGR’s profit will be $16.41 million for 28.75 P/E if the $0.52 EPS becomes a reality. After $0.37 actual earnings per share reported by NETGEAR, Inc. for the previous quarter, Wall Street now forecasts 40.54% EPS growth.

Since December 11, 2017, it had 1 buying transaction, and 29 insider sales for $6.19 million activity. 13,999 shares valued at $768,977 were sold by LO PATRICK CS on Thursday, March 1. Shares for $162,150 were sold by MERRILL MARK G. $36,991 worth of NETGEAR, Inc. (NASDAQ:NTGR) shares were sold by FALCON MICHAEL F. Collins Patrick J III sold 750 shares worth $45,075. $89,100 worth of NETGEAR, Inc. (NASDAQ:NTGR) shares were sold by Rogers Tamesa. $81,381 worth of stock was sold by Henry David John on Thursday, March 1. On Tuesday, February 20 the insider Kim Andrew Wonki sold $33,258.

Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. The company has market cap of $159.15 million. The Company’s Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. It currently has negative earnings. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa , which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients.

NETGEAR, Inc. (NASDAQ:NTGR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: